Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever

One of the biggest gambles in the history of the life sciences industry made it to Wall Street this evening when Moderna, a developer of messenger RNA drugs—an unproven technology with enormous potential—priced the largest biotech IPO ever.